fluorodeoxyglucose f18 has been researched along with pirarubicin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Aono, M; Matsuo, K; Shimada, H; Yago, K; Yanagita, S | 1 |
| Hosokai, R; Imai, C; Imamura, M; Iwabuchi, H; Takachi, T; Uchiyama, M; Yoshida, S | 1 |
| Hara, M; Kohashi, S; Miyagawa, M; Miyazaki, Y; Nakase, K; Nawa, Y; Yasukawa, M | 1 |
| Fujisawa, S; Hashimoto, C; Hattori, Y; Ishigatsubo, Y; Sakai, R; Taguchi, J; Takasaki, H; Tateishi, U; Tomita, N | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and pirarubicin
| Article | Year |
|---|---|
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
4 other study(ies) available for fluorodeoxyglucose f18 and pirarubicin
| Article | Year |
|---|---|
[Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Renal Insufficiency; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vascular Neoplasms; Vindesine | 2009 |
Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Palatine Tonsil; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tonsillar Neoplasms; Vincristine | 2011 |
Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Prednisolone; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2013 |
Post-therapy ¹⁸F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prednisolone; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 2015 |